U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery
Multinational study expected to include clinical sites in U.S. Israel and Europe, where study has been awarded an $8.7 million grant from European Horizon 2020 Program April 25, 2018 07:00 ET | HAIFA, Israel, April 25, [...]
The Rise of #Nanomedicine
APRIL 18, 2018 | Research | NanoMagazine Medicine has been around for thousands of years, but as always, medicine is changing. Throughout the years, humans have switched from apothecary to packing active pharmaceutical ingredients (APIs) into [...]
CytoReason uses AI to personalize #drugs, opening the door to #cancer treatments
STEWART ROGERS | APRIL 16, 2018 8:30 AM The first question most people have when talking about #artificialIntelligence is if it will help us or harm us. But in the health industry, the answer to that [...]
Spotlight On Israel: Market Challenges Stunting Biopharma Growth
23 Apr 2018 | Lucie Ellis Executive Summary Scrip investigates the big issues Israel's #biopharma sector need to overcome in order to maintain momentum and achieve sustainable success. AHARON AHARON, CEO OF THE ISRAEL INNOVATION AUTHORITY. Source: [...]
MIXiii-Biomed 2018 Early Bird Registration – one week left
1 (ONE) Week to Go… Early Bird Registration Deadline Israel remains one of the superpowers in the field of Nanotechnology, with far-reaching effects into many diverse industries, one of which is Biomedicine. MIXiii-Biomed 2018 [...]
(Personalized medicine is approaching a major breakthrough” (Hebrew”
"הרפואה המותאמת אישית מתקרבת לפריצת דרך משמעותית" פרופ' דיוויד סידרנסקי, חוקר סרטן נודע בארה"ב ומנהל קרן השקעות הביומד בישראל (IBF), מסביר בראיון ל"גלובס" מדוע רק עכשיו הרפואה המותאמת אישית עומדת להצדיק את ההייפ שהיה [...]